Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …

Lung cancer (LC) is the leading cause of cancer-related deaths, responsible for
approximately 18.4% of all cancer mortalities in both sexes combined. The use of systemic …

Brain cancers, mainly high-grade gliomas/glioblastoma, are characterized by uncontrolled
proliferation and recurrence with an extremely poor prognosis. Despite various conventional …

Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors addresses brain
anatomy and tumors and the progress and challenges in delivering drugs across the blood …

Tacrine (TAC) was the first FDA approved drug for the treatment of Alzheimer's disease,
resulting in increased memory and enhanced cognitive symptoms in patients. However, long …

The aim of the study was to prepare nanostructured lipid carriers (NLCs) co-encapsulated
with Quercetin and Morin and to compare the cytotoxicity of the NLCs with individual drugs …

Drug targeting for brain malignancies is restricted due to the presence of the blood–brain
barrier (BBB) and blood–brain tumor barrier (BBTB), which act as barriers between the …

It is well documented that cancer is one of the leading causes of death worldwide. During
the pandemic, cancer screening was suspended, and only symptomatic patients were …

Objective: Brain tumors are the most challenging of all tumors and accounts for about 3% of
all cancer allied deaths. The aim of the present review is to examine the brain tumor …

Cancer is considered the second-leading cause of morbidity and mortality worldwide. The
most commonly occurring cancers include breast, lung, liver, prostate, colon, and rectum …